Skip to content

Trial · Interventional

CompletedPhase 4Registry data

Fixed Versus Flexible Gonadotropin-releasing Hormone (GnRH) Antagonist Initiation

NCTNCT01005784 (opens ClinicalTrials.gov in a new tab)Other idUHR-3
Open at ClinicalTrials.govAsk about this trial

Overview

Status
Completed
Phase
Phase 4
Enrollment
146 participants (actual)
Sponsor
Aristotle University Of Thessaloniki · Other
Design
Randomized · Open label (no masking)
Countries
1 country

Greece

Start
Jun 2005
Primary completion
Jan 2008
Completion
Mar 2008
First posted
2 Nov 2009 (estimated)
Last update posted
2 Nov 2009 (estimated)
Conditions
Subfertility

Timeline

1 trial · 1 completed

  • Completed
  • Ongoing
  • Not yet recruiting
  • Stopped
  • Estimated dates (est.)
  • Results posted
20052006200720082009
  1. Ph 4

    Fixed Versus Flexible Gonadotropin-releasing Hormone (GnRH) Antagonist Initiation

    NCT01005784

    Jun 2005 to Mar 2008

Registry summary

Text and fields below are the sponsor's entries at ClinicalTrials.gov, shown as posted.

This is a comparison of pregnancy achievement between two GnRH antagonist protocols which differ in the timing of GnRH antagonist initiation.

Interventions

  • Cetrorelix (Cetrotide)Drug
  • Cetrorelix (Cetrotide)Drug

Arms2

  • Active comparator

    fixed

  • Experimental

    flexible

Primary outcomes1

Outcomes the sponsor listed as primary.

  1. Luteinizing hormone rise

    Time frame · 3-14 days (duration of ovarian stimulation)

Posted results

Values are shown as posted at ClinicalTrials.gov, with their units. PepBank has not converted, pooled or compared them.

No results are posted for this trial.

Completed trials do not always post results.

Registry data comes from ClinicalTrials.gov. Study results come from studies, not from the registry. How PepBank works

Studies1

Studies that cite this trial.

Studies with results

1 study on this page

Indexing hint: Randomized controlled trial · 2011

2 results

Fixed versus flexible gonadotropin-releasing hormone antagonist administration in in vitro fertilization: a randomized controlled trial.

Kolibianakis et al. 2011Fertility and sterilitycited by 37

PMID 20637457DOI 10.1016/j.fertnstert.2010.05.052PUB-20637457

Full text at the publisher2 results
Publisher pageSee results (2)

Eligibility

Who could join, as posted.

Sex
Female
Age
from 18 Years up to 39 Years
Healthy volunteers
Not accepted
Inclusion and exclusion criteria, as posted
Inclusion Criteria: * \< 39 years of age * BMI 18.5-29.9 * \<= 3 previous IVF cycles Exclusion Criteria: * PCOS * Endometriosis

PepBank is a research reference. Talk to a doctor before you use any peptide.